nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—Lacrimal structural disorder—Docetaxel—head and neck cancer	0.0235	0.0235	CcSEcCtD
Gadopentetate dimeglumine—Nystagmus—Vinblastine—head and neck cancer	0.0204	0.0204	CcSEcCtD
Gadopentetate dimeglumine—Lacrimation—Fluorouracil—head and neck cancer	0.0163	0.0163	CcSEcCtD
Gadopentetate dimeglumine—Lacrimal disorder—Docetaxel—head and neck cancer	0.0154	0.0154	CcSEcCtD
Gadopentetate dimeglumine—Chest tightness—Docetaxel—head and neck cancer	0.0147	0.0147	CcSEcCtD
Gadopentetate dimeglumine—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.014	0.014	CcSEcCtD
Gadopentetate dimeglumine—Nystagmus—Fluorouracil—head and neck cancer	0.0134	0.0134	CcSEcCtD
Gadopentetate dimeglumine—Phlebitis—Vinblastine—head and neck cancer	0.0123	0.0123	CcSEcCtD
Gadopentetate dimeglumine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0118	0.0118	CcSEcCtD
Gadopentetate dimeglumine—Deafness—Vinblastine—head and neck cancer	0.0118	0.0118	CcSEcCtD
Gadopentetate dimeglumine—Lacrimation—Docetaxel—head and neck cancer	0.0117	0.0117	CcSEcCtD
Gadopentetate dimeglumine—Deep vein thrombosis—Docetaxel—head and neck cancer	0.0113	0.0113	CcSEcCtD
Gadopentetate dimeglumine—Eye irritation—Fluorouracil—head and neck cancer	0.0112	0.0112	CcSEcCtD
Gadopentetate dimeglumine—Speech disorder—Fluorouracil—head and neck cancer	0.0111	0.0111	CcSEcCtD
Gadopentetate dimeglumine—Disorientation—Hydroxyurea—head and neck cancer	0.0108	0.0108	CcSEcCtD
Gadopentetate dimeglumine—Parosmia—Docetaxel—head and neck cancer	0.0106	0.0106	CcSEcCtD
Gadopentetate dimeglumine—Renal failure acute—Hydroxyurea—head and neck cancer	0.0104	0.0104	CcSEcCtD
Gadopentetate dimeglumine—Lacrimation increased—Fluorouracil—head and neck cancer	0.0104	0.0104	CcSEcCtD
Gadopentetate dimeglumine—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.0102	0.0102	CcSEcCtD
Gadopentetate dimeglumine—Laryngeal pain—Docetaxel—head and neck cancer	0.0101	0.0101	CcSEcCtD
Gadopentetate dimeglumine—Burning sensation—Docetaxel—head and neck cancer	0.00993	0.00993	CcSEcCtD
Gadopentetate dimeglumine—Throat sore—Docetaxel—head and neck cancer	0.00957	0.00957	CcSEcCtD
Gadopentetate dimeglumine—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00949	0.00949	CcSEcCtD
Gadopentetate dimeglumine—Face oedema—Hydroxyurea—head and neck cancer	0.00931	0.00931	CcSEcCtD
Gadopentetate dimeglumine—Scotoma—Docetaxel—head and neck cancer	0.00909	0.00909	CcSEcCtD
Gadopentetate dimeglumine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00903	0.00903	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Vinblastine—head and neck cancer	0.0089	0.0089	CcSEcCtD
Gadopentetate dimeglumine—Coma—Fluorouracil—head and neck cancer	0.00874	0.00874	CcSEcCtD
Gadopentetate dimeglumine—Rhinorrhoea—Docetaxel—head and neck cancer	0.00852	0.00852	CcSEcCtD
Gadopentetate dimeglumine—Eye irritation—Docetaxel—head and neck cancer	0.00808	0.00808	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00803	0.00803	CcSEcCtD
Gadopentetate dimeglumine—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00802	0.00802	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Vinblastine—head and neck cancer	0.00799	0.00799	CcSEcCtD
Gadopentetate dimeglumine—Chest discomfort—Docetaxel—head and neck cancer	0.0078	0.0078	CcSEcCtD
Gadopentetate dimeglumine—Disorientation—Fluorouracil—head and neck cancer	0.00776	0.00776	CcSEcCtD
Gadopentetate dimeglumine—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00759	0.00759	CcSEcCtD
Gadopentetate dimeglumine—Lacrimation increased—Docetaxel—head and neck cancer	0.00749	0.00749	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Hydroxyurea—head and neck cancer	0.00743	0.00743	CcSEcCtD
Gadopentetate dimeglumine—Blood bilirubin increased—Docetaxel—head and neck cancer	0.0073	0.0073	CcSEcCtD
Gadopentetate dimeglumine—Hearing impaired—Docetaxel—head and neck cancer	0.00725	0.00725	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00703	0.00703	CcSEcCtD
Gadopentetate dimeglumine—Blood pressure increased—Docetaxel—head and neck cancer	0.0069	0.0069	CcSEcCtD
Gadopentetate dimeglumine—Injection site reaction—Docetaxel—head and neck cancer	0.00686	0.00686	CcSEcCtD
Gadopentetate dimeglumine—Cardiac arrest—Fluorouracil—head and neck cancer	0.0066	0.0066	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00621	0.00621	CcSEcCtD
Gadopentetate dimeglumine—Lightheadedness—Docetaxel—head and neck cancer	0.00617	0.00617	CcSEcCtD
Gadopentetate dimeglumine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00614	0.00614	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Hydroxyurea—head and neck cancer	0.00605	0.00605	CcSEcCtD
Gadopentetate dimeglumine—Chills—Hydroxyurea—head and neck cancer	0.00599	0.00599	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Fluorouracil—head and neck cancer	0.00584	0.00584	CcSEcCtD
Gadopentetate dimeglumine—Phlebitis—Docetaxel—head and neck cancer	0.00581	0.00581	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Hydroxyurea—head and neck cancer	0.00581	0.00581	CcSEcCtD
Gadopentetate dimeglumine—Thrombophlebitis—Docetaxel—head and neck cancer	0.00579	0.00579	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Vinblastine—head and neck cancer	0.00574	0.00574	CcSEcCtD
Gadopentetate dimeglumine—Deafness—Docetaxel—head and neck cancer	0.0056	0.0056	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Vinblastine—head and neck cancer	0.00552	0.00552	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Vinblastine—head and neck cancer	0.0055	0.0055	CcSEcCtD
Gadopentetate dimeglumine—Visual disturbance—Docetaxel—head and neck cancer	0.00529	0.00529	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00527	0.00527	CcSEcCtD
Gadopentetate dimeglumine—Renal impairment—Docetaxel—head and neck cancer	0.00526	0.00526	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00524	0.00524	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Hydroxyurea—head and neck cancer	0.00524	0.00524	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Fluorouracil—head and neck cancer	0.0052	0.0052	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Hydroxyurea—head and neck cancer	0.00503	0.00503	CcSEcCtD
Gadopentetate dimeglumine—Pain in extremity—Docetaxel—head and neck cancer	0.00501	0.00501	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Vinblastine—head and neck cancer	0.00495	0.00495	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Docetaxel—head and neck cancer	0.00493	0.00493	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00491	0.00491	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Fluorouracil—head and neck cancer	0.00481	0.00481	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Vinblastine—head and neck cancer	0.00467	0.00467	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00465	0.00465	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Hydroxyurea—head and neck cancer	0.0046	0.0046	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Docetaxel—head and neck cancer	0.00458	0.00458	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Hydroxyurea—head and neck cancer	0.00452	0.00452	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Vinblastine—head and neck cancer	0.00452	0.00452	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00451	0.00451	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Docetaxel—head and neck cancer	0.00448	0.00448	CcSEcCtD
Gadopentetate dimeglumine—Pain—Vinblastine—head and neck cancer	0.00444	0.00444	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Vinblastine—head and neck cancer	0.00444	0.00444	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Fluorouracil—head and neck cancer	0.00429	0.00429	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Vinblastine—head and neck cancer	0.00428	0.00428	CcSEcCtD
Gadopentetate dimeglumine—Bronchospasm—Docetaxel—head and neck cancer	0.00426	0.00426	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00425	0.00425	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00423	0.00423	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Docetaxel—head and neck cancer	0.00422	0.00422	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Hydroxyurea—head and neck cancer	0.00421	0.00421	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Fluorouracil—head and neck cancer	0.00418	0.00418	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00412	0.00412	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Vinblastine—head and neck cancer	0.00411	0.00411	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00409	0.00409	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Hydroxyurea—head and neck cancer	0.00409	0.00409	CcSEcCtD
Gadopentetate dimeglumine—Pain—Hydroxyurea—head and neck cancer	0.00405	0.00405	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Hydroxyurea—head and neck cancer	0.00405	0.00405	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00391	0.00391	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Vinblastine—head and neck cancer	0.00383	0.00383	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00381	0.00381	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Docetaxel—head and neck cancer	0.00379	0.00379	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Docetaxel—head and neck cancer	0.00378	0.00378	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Docetaxel—head and neck cancer	0.00375	0.00375	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00375	0.00375	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Vinblastine—head and neck cancer	0.00373	0.00373	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00365	0.00365	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Fluorouracil—head and neck cancer	0.00362	0.00362	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Fluorouracil—head and neck cancer	0.00356	0.00356	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Vinblastine—head and neck cancer	0.00356	0.00356	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00349	0.00349	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Docetaxel—head and neck cancer	0.00347	0.00347	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Fluorouracil—head and neck cancer	0.00344	0.00344	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Vinblastine—head and neck cancer	0.00344	0.00344	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Docetaxel—head and neck cancer	0.00342	0.00342	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Docetaxel—head and neck cancer	0.00341	0.00341	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00341	0.00341	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Docetaxel—head and neck cancer	0.00341	0.00341	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Hydroxyurea—head and neck cancer	0.0034	0.0034	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Docetaxel—head and neck cancer	0.0034	0.0034	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00335	0.00335	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Docetaxel—head and neck cancer	0.00334	0.00334	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Fluorouracil—head and neck cancer	0.00333	0.00333	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Vinblastine—head and neck cancer	0.0033	0.0033	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Docetaxel—head and neck cancer	0.00328	0.00328	CcSEcCtD
Gadopentetate dimeglumine—Headache—Vinblastine—head and neck cancer	0.00326	0.00326	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Fluorouracil—head and neck cancer	0.00325	0.00325	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00324	0.00324	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Docetaxel—head and neck cancer	0.00324	0.00324	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Docetaxel—head and neck cancer	0.00322	0.00322	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Docetaxel—head and neck cancer	0.00322	0.00322	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Fluorouracil—head and neck cancer	0.00319	0.00319	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Docetaxel—head and neck cancer	0.00314	0.00314	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Hydroxyurea—head and neck cancer	0.00313	0.00313	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Docetaxel—head and neck cancer	0.00313	0.00313	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00312	0.00312	CcSEcCtD
Gadopentetate dimeglumine—Chills—Docetaxel—head and neck cancer	0.00311	0.00311	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00311	0.00311	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Docetaxel—head and neck cancer	0.0031	0.0031	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Vinblastine—head and neck cancer	0.00309	0.00309	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Fluorouracil—head and neck cancer	0.00306	0.00306	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Fluorouracil—head and neck cancer	0.00304	0.00304	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Docetaxel—head and neck cancer	0.00304	0.00304	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Fluorouracil—head and neck cancer	0.00303	0.00303	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Docetaxel—head and neck cancer	0.00302	0.00302	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Hydroxyurea—head and neck cancer	0.00301	0.00301	CcSEcCtD
Gadopentetate dimeglumine—Rash—Hydroxyurea—head and neck cancer	0.00299	0.00299	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Hydroxyurea—head and neck cancer	0.00299	0.00299	CcSEcCtD
Gadopentetate dimeglumine—Headache—Hydroxyurea—head and neck cancer	0.00297	0.00297	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Fluorouracil—head and neck cancer	0.00297	0.00297	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Docetaxel—head and neck cancer	0.00295	0.00295	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00295	0.00295	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Docetaxel—head and neck cancer	0.00292	0.00292	CcSEcCtD
Gadopentetate dimeglumine—Pain—Fluorouracil—head and neck cancer	0.00292	0.00292	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Hydroxyurea—head and neck cancer	0.00282	0.00282	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00281	0.00281	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Fluorouracil—head and neck cancer	0.00271	0.00271	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Docetaxel—head and neck cancer	0.00271	0.00271	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Fluorouracil—head and neck cancer	0.0027	0.0027	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Docetaxel—head and neck cancer	0.00265	0.00265	CcSEcCtD
Gadopentetate dimeglumine—Cough—Docetaxel—head and neck cancer	0.00263	0.00263	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Docetaxel—head and neck cancer	0.00261	0.00261	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Docetaxel—head and neck cancer	0.0026	0.0026	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Docetaxel—head and neck cancer	0.00257	0.00257	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Docetaxel—head and neck cancer	0.00257	0.00257	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00255	0.00255	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00251	0.00251	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Docetaxel—head and neck cancer	0.00251	0.00251	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Docetaxel—head and neck cancer	0.00248	0.00248	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00246	0.00246	CcSEcCtD
Gadopentetate dimeglumine—Shock—Docetaxel—head and neck cancer	0.00242	0.00242	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Docetaxel—head and neck cancer	0.00241	0.00241	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Fluorouracil—head and neck cancer	0.00241	0.00241	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Docetaxel—head and neck cancer	0.0024	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Docetaxel—head and neck cancer	0.00239	0.00239	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Docetaxel—head and neck cancer	0.00235	0.00235	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Fluorouracil—head and neck cancer	0.00233	0.00233	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Docetaxel—head and neck cancer	0.0023	0.0023	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Fluorouracil—head and neck cancer	0.00226	0.00226	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00224	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Docetaxel—head and neck cancer	0.00221	0.00221	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Docetaxel—head and neck cancer	0.0022	0.0022	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Docetaxel—head and neck cancer	0.00219	0.00219	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Fluorouracil—head and neck cancer	0.00217	0.00217	CcSEcCtD
Gadopentetate dimeglumine—Rash—Fluorouracil—head and neck cancer	0.00215	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Fluorouracil—head and neck cancer	0.00215	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Docetaxel—head and neck cancer	0.00214	0.00214	CcSEcCtD
Gadopentetate dimeglumine—Headache—Fluorouracil—head and neck cancer	0.00214	0.00214	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00213	0.00213	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Docetaxel—head and neck cancer	0.00212	0.00212	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Docetaxel—head and neck cancer	0.00211	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Pain—Docetaxel—head and neck cancer	0.00211	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Docetaxel—head and neck cancer	0.00203	0.00203	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Fluorouracil—head and neck cancer	0.00203	0.00203	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00201	0.00201	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Docetaxel—head and neck cancer	0.00195	0.00195	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Docetaxel—head and neck cancer	0.00195	0.00195	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Docetaxel—head and neck cancer	0.00181	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Docetaxel—head and neck cancer	0.00177	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Docetaxel—head and neck cancer	0.00174	0.00174	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Docetaxel—head and neck cancer	0.00168	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Docetaxel—head and neck cancer	0.00163	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Docetaxel—head and neck cancer	0.00157	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Rash—Docetaxel—head and neck cancer	0.00155	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Docetaxel—head and neck cancer	0.00155	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Headache—Docetaxel—head and neck cancer	0.00154	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Docetaxel—head and neck cancer	0.00146	0.00146	CcSEcCtD
